Contextual cues from cancer cells govern cancer-associated fibroblast heterogeneity is a research paper published in Cell Reports (2021). On theSindex it has a DataRank of 0. It has been cited 32 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph â no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full â never from an abstract alone.
National Research Foundation of Korea
Grant: NRF-2020R1A5A2019210
National Research Foundation of Korea
Grant: NCI P30 CA16672
National Institutes of Health
Grant: P30 CA125123
National Institutes of Health
Grant: R01 CA196205
National Institutes of Health
Grant: R01 CA181184
National Institutes of Health
Grant: R01 CA2111125
National Institutes of Health
Grant: S10 RR024574
US Department of Defense
Grant: W81XWH-07-1-0306
University of Texas MD Anderson Cancer Center
Grant: RP190682
University of Texas MD Anderson Cancer Center
Grant: CPRIT-RP180672
National Cancer Institute
Grant: 1-P50-CA70907-01
NCI NIH HHS
Grant: K99 CA225633
NCI NIH HHS
Grant: R01 CA211125
NCI NIH HHS
Grant: R01 CA223758
NCI NIH HHS
Grant: P50 CA070907
NCI NIH HHS
Grant: R01 CA236781
NCI NIH HHS
Grant: P30 CA016672
NCI NIH HHS
Grant: R00 CA225633
National Institutes of Health
Grant: 5R01CA181184-05
Regulation of Lung Cancer Metastasis by ZEB1
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
National Institutes of Health
Grant: 1S10RR024574-01A1
BD Biosciences Special Order LSRII
National Institutes of Health
Grant: 3P50CA070907-02S1
UNIVERSITY OF TEXAS--SPORE IN LUNG CANCER
National Institutes of Health
Grant: 5R01CA196205-03
NOVEL SMALL MOLECULE INHIBITION OF DDR2 TO PREVENT BREAST CANCER METASTASIS
National Institutes of Health
Grant: 3P30CA125123-09S3
Baylor College of Medicine Cancer Center
Fundação para a CiĂȘncia e a Tecnologia, I.P.
Grant: Incentivo/SAU/LA0001/2013
Incentive - LA 1 - 2013
CPRIT
Halozyme
Merck
AstraZeneca
Takeda Pharmaceutical Company
Sanofi
Novartis
Bayer Fund
GlaxoSmithKline
Janssen Pharmaceuticals
Johnson and Johnson
FWCI
1.78
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals